RSI spoločnosti Cellectis
Aká je hodnota metriky RSI spoločnosti Cellectis?
Hodnota metriky RSI spoločnosti Cellectis je 55.61
Aká je definícia metriky RSI?
Index relatívnej sily (Relative strength index - RSI 14) je technický ukazovateľ, ktorý sa radí medzi momentum indikátory a meria rýchlosť a zmenu ceny. Jeho hodnota sa pohybuje medzi 0 a 100 a používa sa na charakterizovanie prekupovaného a prepredaného stavu.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Cellectis
Čomu sa venuje spoločnosť Cellectis?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Firmy s metrikou rsi podobnou spoločnosti Cellectis
- Hodnota metriky RSI spoločnosti Laurion Mineral Exploration je 55.60
- Hodnota metriky RSI spoločnosti Cymbria je 55.60
- Hodnota metriky RSI spoločnosti Veto Switchgears and Cables je 55.60
- Hodnota metriky RSI spoločnosti North American Nickel je 55.60
- Hodnota metriky RSI spoločnosti Alimera Sciences je 55.60
- Hodnota metriky RSI spoločnosti Redcape Hotel je 55.60
- Hodnota metriky RSI spoločnosti Cellectis je 55.61
- Hodnota metriky RSI spoločnosti American Pacific Borates je 55.62
- Hodnota metriky RSI spoločnosti Interface je 55.62
- Hodnota metriky RSI spoločnosti Paragon ID SA je 55.62
- Hodnota metriky RSI spoločnosti WestRock je 55.62
- Hodnota metriky RSI spoločnosti Facebank je 55.62
- Hodnota metriky RSI spoločnosti Drax plc je 55.62